S-Trityl-L-cysteine
CAS No. 2799-07-7
S-Trityl-L-cysteine ( NSC 83265 )
产品货号. M13853 CAS No. 2799-07-7
S-Trityl-L-cysteine (NSC 83265) is a potent, cell-permeable, selective inhibitor of mitotic kinesin Eg5, inhibits basal ATPase activity (IC50=1 mM) and microtubule-activated ATPase activity of Eg5 (IC50=140 nM).
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
50MG | ¥316 | 有现货 |
|
100MG | ¥446 | 有现货 |
|
200MG | ¥648 | 有现货 |
|
500MG | ¥1077 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称S-Trityl-L-cysteine
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述S-Trityl-L-cysteine (NSC 83265) is a potent, cell-permeable, selective inhibitor of mitotic kinesin Eg5, inhibits basal ATPase activity (IC50=1 mM) and microtubule-activated ATPase activity of Eg5 (IC50=140 nM).
-
产品描述S-Trityl-L-cysteine (NSC 83265) is a potent, cell-permeable, selective inhibitor of mitotic kinesin Eg5, inhibits basal ATPase activity (IC50=1 mM) and microtubule-activated ATPase activity of Eg5 (IC50=140 nM); induces mitotic arrest in HeLa cells with an IC50 of 700 nM, and displays antitumor activity.
-
同义词NSC 83265
-
通路Cytoskeleton/Cell Adhesion Molecules
-
靶点Kinesin
-
受体Kinesin
-
研究领域——
-
适应症——
化学信息
-
CAS Number2799-07-7
-
分子量363.47
-
分子式C22H21NO2S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)SCC(C(=O)O)N
-
化学全称S-(Triphenylmethyl)-L-cysteine
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Brier S, et al. Biochemistry. 2004 Oct 19;43(41):13072-82.
2. DeBonis S, et al. Mol Cancer Ther. 2004 Sep;3(9):1079-90.
3. Zhao J, et al. Am J Cancer Res. 2014 Jan 15;4(1):42-52.
2. DeBonis S, et al. Mol Cancer Ther. 2004 Sep;3(9):1079-90.
3. Zhao J, et al. Am J Cancer Res. 2014 Jan 15;4(1):42-52.
产品手册
关联产品
-
S-Trityl-L-cysteine
S-Trityl-L-cysteine (NSC 83265) is a potent, cell-permeable, selective inhibitor of mitotic kinesin Eg5, inhibits basal ATPase activity (IC50=1 mM) and microtubule-activated ATPase activity of Eg5 (IC50=140 nM).
-
TCS-OX2-29
TCS-OX2-29 is a potent and selective OX2 receptor antagonist (IC50: 40 nM). It displays >250-fold selectivity for OX2 over OX1.
-
Merestinib
LY2801653 is an orally available, small molecule inhibitor of the proto-oncogene c-Met (Ki: 2 nM) with potential antineoplastic activity.